Overview
Timothy Rearden is an Oncologist in Florissant, Missouri. Dr. Rearden is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Paget Disease of the Breast, Angiosarcoma, Inflammatory Breast Cancer, and Lung Cancer.
His clinical research consists of co-authoring 4 peer reviewed articles and participating in 16 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
16 Clinical Trials
Washington University
Joel Picus is an Oncologist in Saint Louis, Missouri. Dr. Picus is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, and Orchiectomy. Dr. Picus is currently accepting new patients.
James Hsieh is an Oncologist in Saint Louis, Missouri. Dr. Hsieh is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Wilms Tumor, Familial Wilms Tumor 2, Renal Cell Carcinoma (RCC), and Chromophobe Renal Cell Carcinoma.
Washington University
Bruce Roth is an Oncologist in Saint Louis, Missouri. Dr. Roth is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Testicular Cancer, Familial Prostate Cancer, and Renal Cell Carcinoma (RCC). Dr. Roth is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Rearden isDistinguished. Learn about Angiosarcoma.
- Breast CancerDr. Rearden isDistinguished. Learn about Breast Cancer.
- Inflammatory Breast CancerDr. Rearden isDistinguished. Learn about Inflammatory Breast Cancer.
- Lung CancerDr. Rearden isDistinguished. Learn about Lung Cancer.
- Paget Disease of the BreastDr. Rearden isDistinguished. Learn about Paget Disease of the Breast.
- Pleuropulmonary BlastomaDr. Rearden isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- Clear Cell SarcomaDr. Rearden isAdvanced. Learn about Clear Cell Sarcoma.
- Colorectal CancerDr. Rearden isAdvanced. Learn about Colorectal Cancer.
- EGFR Positive Lung CancerDr. Rearden isAdvanced. Learn about EGFR Positive Lung Cancer.
- Familial Colorectal CancerDr. Rearden isAdvanced. Learn about Familial Colorectal Cancer.
- Large-Cell Lung CarcinomaDr. Rearden isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Rearden isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaDr. Rearden isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Rearden isExperienced. Learn about Agranulocytosis.
- Anal CancerDr. Rearden isExperienced. Learn about Anal Cancer.